翱路医药(OTR Therapeutics)致力于将早期创新转化为在免疫、肿瘤、心脏代谢等重要疾病领域具有全球影响力的临床新药。我们通过“引进+自研”双轮驱动模式,甄选和开发具有差异化优势的早期项目,凭借严谨高效的研发体系与灵活多元的合作机制,加速推进全球临床开发,打造具有国际竞争力的治疗方案。通过与全球创新力量深度协同、持续推动早期创新成果的国际转化,我们期待为合作伙伴创造卓越价值、为全球患者带来切实福祉。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows